JPRN-UMIN000021677
Completed
未知
the utility of dynamic contrase-enhanced MRI for advanced and metastatic breast cancer administerd with bevacizumab - the utility of dynamic contrase-enhanced MRI for advanced and metastatic breast cancer administerd with bevacizumab
Conditionsbreast cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- breast cancer
- Sponsor
- kyoto prefectural university of medicine
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)be pregnant or possible to pregnancy 2\)with active breast cancer 3\)with severe complications 4\)with uncontrolled pleural effusion,ascites and edema 5\)with brain metastasis 6\)doctor's decision not to be registered to this study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Dynamic contrast enhanced MRI (DCE-MRI) assessment of the vascular changes induced with bevacizumab alone and in combination with interferon-a in patients with advanced renal cell carcinoma. - DCE-MRI changes in tumour vaculature with Bevacizumab and Interferon in advanced RCCPreviously untreated metastatic (stage IV) or locally advanced (inoperable stage III), renal cell carcinomaMedDRA version: 9.1Level: HLTClassification code 10038408Term: Renal cell carcinomasEUCTR2008-006414-19-GBEast and North Hertfordhsire NHS Trust30
Not yet recruiting
Not Applicable
Variability of dynamic contrast-enhanced MRI in the pituitary adenoma: Prospective comparison between gadobutrol and meglumine gadoterate usageKCT0006668Seoul National University Bundang Hospital74
Completed
Not Applicable
DCE-MRI for Assessment of Response to TACE of HCCCarcinoma, HepatocellularNCT02878109Centre hospitalier de l'Université de Montréal (CHUM)40
Not yet recruiting
Not Applicable
The role of non-contrast abbreviated MRI for secondary surveillance of hepatocellular carcinoma after curative treatment: prospective multicenter studyKCT0006395Seoul National University Hospital210
Active, not recruiting
Not Applicable
Differences in dynamic contrast-enhanced (DCE) MRI measurements using Magnevist (Gd-DTPA) and Vas-ovist in patients with untreated squamous cell cervical carcinoma. - NDntreated squamous cell cervical carcinoma(SCCC).MedDRA version: 9.1Level: HLTClassification code 10029109Term: Cervix neoplasmsEUCTR2008-002958-37-ITISTITUTO EUROPEO DI ONCOLOGIA